The molecular benefits of PCR in platforms testing for COVID-19 and influenza
Discover how real-time analytics of your laboratory assays can provide valuable insights through key metrics, such as test outcomes, assay performance, and laboratory proficiency monitoring, including cross-assay comparisons. As laboratories move beyond COVID testing, there are many advantages to using multiplex PCR tests in the management of respiratory tract infections.
- Examine various scenarios of diagnostics latency and care gaps, including the potential impact on patient outcome
- Analytical and practical performance difference between different platforms
- Learn more about the benefits of multiplex PCR testing
Featured Speakers:
Anami Patel, Ph.D.
Chief Science Officer, Poplar Healthcare
Imran Mujawar, MBBS, MS
Sr. Staff Data Scientist, Thermo Fisher Scientific
Moderator:
Manoj Gandhi, M.D., Ph.D.
Senior Director of Medical and Scientific Affairs, Thermo Fisher Scientific